Werkgroep Cardiologische centra Nederland English

AEGIS-II (Includerend)

A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome
Middel
CSL112
Populatie
ASCVD
Fase
III
Jaar aanvang
2017